Ausgabe 6/2016
Inhalt (18 Artikel)
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Improving Prognostic Modeling in Myelodysplastic Syndromes
Aziz Nazha, Mikkael A. Sekeres
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Assessing Quality of Care for the Myelodysplastic Syndromes
Zachary A. K. Frosch, Gregory A. Abel
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms
Charlotte K. Brierley, David P. Steensma
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring Sideroblasts
Anna Mies, Olivier Hermine, Uwe Platzbecker
- Myelodysplastic Syndromes (D Steensma, Section Editor)
An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T
Chetasi Talati, Eric Padron
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Palliative and End-of-Life Care in Myelodysplastic Syndromes
Myles Nickolich, Areej El-Jawahri, Thomas W. LeBlanc
- Myelodysplastic Syndromes (D Steensma, Section Editor)
Molecular Testing in Patients with Suspected Myelodysplastic Syndromes
Tamara K. Moyo, Michael R. Savona
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer
Miguel-Angel Perales, Emily K. Drake, Naveen Pemmaraju, William A. Wood
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, Jean-Jacques Kiladjian, Ruben Mesa, Michael A. Thompson
- Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)
Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Naveen Pemmaraju, Vikas Gupta, Michael A. Thompson, Andrew A. Lane
- T-Cell and Other Lymphoproliferative Malignancies (P Porcu, Section Editor)
Sézary Syndrome: Clinical and Biological Aspects
Rebecca Kohnken, Stephanie Fabbro, Justin Hastings, Pierluigi Porcu, Anjali Mishra
- T-Cell and Other Lymphoproliferative Malignancies (P Porcu, Section Editor)
CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell Lymphomas
Geetika Bhatt, Kami Maddocks, Beth Christian
- T-Cell and Other Lymphoproliferative Malignancies (P Porcu, Section Editor)
T-cell Lymphoma Epidemiology: the Known and Unknown
Anh Phan, Rachel Veldman, Mary Jo Lechowicz
- T-CELL AND OTHER LYMPHOPROLIFERATIVE MALIGNANCIES (P PORCU, SECTION EDITOR)
Enteropathy-Associated T-Cell Lymphoma
Sarah Ondrejka, Deepa Jagadeesh
- T-Cell and Other Lymphoproliferative Malignancies (P Porcu, Section Editor)
Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases
Bradley M. Haverkos, Zenggang Pan, Alejandro A. Gru, Aharon G. Freud, Rachel Rabinovitch, Meng Xu-Welliver, Brad Otto, Carlos Barrionuevo, Robert A. Baiocchi, Rosemary Rochford, Pierluigi Porcu
- Acute Myeloid Leukemias (H Erba, Section Editor)
Acute Myeloid Leukemia: How Do We Measure Success?
Joshua P. Sasine, Gary J. Schiller
- Acute Myeloid Leukemias (H Erba, Section Editor)
Definition of Unfit for Standard Acute Myeloid Leukemia Therapy
Heidi D. Klepin
- Acute Myeloid Leukemias (H Erba, Section Editor)
Antibody-Based Treatment of Acute Myeloid Leukemia
Phillip M. Garfin, Eric J. Feldman
